FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Search Results

Semaglutide Injection, Solution
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Revised 09/12/2023)

Company Contact Information:
833-493-4689

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Wegovy, Injection, Solution, .25 mg/.5 mL (NDC 0169-4525-14)	Limited availability. Estimated shortage duration TBD		Demand increase for the drug
Wegovy, Injection, Solution, .5 mg/.5 mL (NDC 0169-4505-14)	Limited availability. Estimated shortage duration TBD		Demand increase for the drug
Wegovy, Injection, Solution, 1 mg/.5 mL (NDC 0169-4501-14)	Limited availability. Estimated shortage duration TBD		Demand increase for the drug
Wegovy, Injection, Solution, 1.7 mg/.75 mL (NDC 0169-4517-14)	Available
Wegovy, Injection, Solution, 2.4 mg/.75 mL (NDC 0169-4524-14)	Available
Ozempic, Injection, Solution, 1.34 mg/1 mL (NDC 0169-4130-13)	Currently available
Ozempic, Injection, Solution, 2.68 mg/1 mL (NDC 0169-4772-12)	Limited availability through end of 2023
Ozempic, Injection, Solution, .68 mg/1 mL (NDC 0169-4181-13)	Currently available